Akebia Therapeutics (AKBA) - Shares outstanding

Number of shares outstanding as of March 2026 : 264,786,432

According to Akebia Therapeutics's latest financial reports and stock price the company's current number of shares outstanding is 264,786,432. At the end of 2025 the company had 264,786,432 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for Akebia Therapeutics from 2013 to 2025

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2025	0.26 B	21.07%
2024	0.21 B	15.16%
2023	0.18 B	3.21%
2022	0.18 B	4.77%
2021	0.17 B	21.01%
2020	0.14 B	21.58%
2019	0.11 B	2.11%
2018	0.11 B	149.02%
2017	46.93 M	23.86%
2016	37.89 M	31.66%
2015	28.78 M	46.18%
2014	19.69 M	94.34%
2013	10.13 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Johnson & Johnson JNJ	2,407,939,000	809.39%	🇺🇸 USA
Novartis NVS	1,913,000,000	622.47%	🇨🇭 Switzerland
Amgen AMGN	539,000,000	103.56%	🇺🇸 USA
Nektar Therapeutics NKTR	16,870,930	-93.63%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for Akebia Therapeutics (AKBA)

Number of shares outstanding as of March 2026 : 264,786,432